---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-086685"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2022-08-05T23:59:59+00:00"
generated_at: "2026-06-24T03:20:34.776914+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Hepion shareholders reject authorized share increase from 120M to 200M

## Summary
- Proposal received 19,267,720 For, 27,847,827 Against, 254,176 Abstain; broker non-votes 1.
- The amendment to the certificate of incorporation was not approved.
- Meeting was previously adjourned to complete voting on this proposal.

## SEC filing metadata
- accession: 0001104659-22-086685
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2022-08-05T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000110465922086685/0001104659-22-086685-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000110465922086685/tm2222710d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-086685
- JSON: https://secwatch.observer/filing/0001104659-22-086685.json
- Plain text: https://secwatch.observer/filing/0001104659-22-086685.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.